Stealth Health Launches Dual-Front U.S. Longevity Medicine Offensive

TORONTO and DALLAS – March 31, 2026 – Canadian longevity medicine leader Stealth Health has officially planted its flag in the United States, announcing today that its American operations have been fully active since January 2026. The company is entering the competitive U.S. market with a formidable two-pronged strategy: a direct-to-patient telemedicine service and an enterprise-level white-label platform for other healthcare organizations.

This move positions the Toronto-based innovator to capitalize on the burgeoning American demand for personalized wellness and anti-aging solutions. The U.S. longevity and wellness market is a rapidly expanding sector, with some projections estimating its value to reach nearly $47 billion by 2031. By offering services like hormone optimization, peptide therapy, and precision wellness protocols directly to consumers, Stealth Health is tapping into a powerful trend of patient empowerment and preventative health.

Simultaneously, by providing its core technology to other businesses, the company is making a strategic play to embed its infrastructure across the broader healthcare landscape. This dual approach signals a deliberate and aggressive plan to capture market share from both the consumer and business-to-business sides of the industry.

A Two-Pronged Strategy for Market Penetration

Stealth Health's U.S. expansion is not a tentative first step but a fully realized, dual-model operation. The first business line is a direct-to-patient virtual clinic. Through its HIPAA-compliant platform, American patients can now receive comprehensive health assessments, consult with board-certified U.S. physicians, and get personalized prescriptions fulfilled by licensed U.S. pharmacies, often with same-day shipping.

The second, and perhaps more strategic, pillar is its white-label enterprise platform. This service allows other healthcare providers, clinics, and wellness brands to launch their own branded telemedicine services without the immense cost and complexity of building the technology from scratch. Partners gain access to Stealth Health's integrated clinical workflows, e-prescribing, and pharmacy fulfillment infrastructure, effectively allowing them to compete in the digital health space under their own brand.

"We didn't just enter the U.S. market – we built it properly from the ground up," said Matthew Mazzuca, Chief Executive Officer of Stealth Health, in a statement. "Our U.S. operations have been fully live since January, and we're now serving patients directly while simultaneously powering other healthcare brands through our white-label platform. This dual approach lets us scale American longevity care from both sides – reaching patients where they are, and giving providers the technology to do the same."

This strategy allows the company to generate revenue directly from its own patient base while also creating a scalable, recurring revenue stream from enterprise clients. It's a model designed to accelerate growth and establish a significant footprint in a crowded market.

The Science of Hyper-Personalization

At the core of Stealth Health's offering is a deep focus on data-driven, personalized medicine, powered by its integration of the Metabolic Code® assessment system. This is the company's answer to the one-size-fits-all approach that often characterizes the wellness industry. The system utilizes comprehensive blood testing and a proprietary framework known as TRIADS™ to analyze a patient's unique physiology.

The platform connects a patient's symptoms, biomarkers, and lifestyle factors to identify the root causes of metabolic and systemic imbalances. This allows physicians to move beyond treating symptoms and instead develop highly personalized vitality and longevity programs that can include targeted nutrition, supplementation, and advanced therapeutics like hormone optimization.

"Metabolic Code was built to scale – and Stealth Health is the perfect partner to bring it to the American market," stated Rob Galarza, CEO of Metabolic Code. He emphasized that the system provides a comprehensive, systems-based approach to patient health. "With Stealth's fully operational U.S. infrastructure, we can now deliver truly personalized care at scale—combining targeted nutrition, supplementation, and advanced therapeutics in a way that's rooted in clinical insight, not guesswork."

This integration serves as a key differentiator, promising a level of clinical rigor and personalization that aims to set it apart from more superficial wellness apps and services. For both its direct-to-patient clients and white-label partners, the inclusion of this sophisticated diagnostic framework is a primary value proposition.

Navigating the Complex U.S. Regulatory Landscape

Launching a telemedicine service in the United States, particularly one involving specialized treatments and prescriptions across state lines, is a monumental regulatory challenge. Stealth Health's announcement highlights a carefully constructed framework designed to ensure full compliance from day one.

The company's U.S. operations are built upon a Management Services Organization (MSO) structure. This model is commonly used in healthcare to separate the clinical aspects of medicine from the business and administrative functions, helping to navigate the complex web of state-specific laws governing medical practice and corporate ownership of clinics.

This MSO framework is supported by a network of board-certified American physicians who provide local oversight and care, ensuring compliance with state medical licensing laws. Furthermore, the firm has established partnerships with licensed U.S. pharmacies to handle prescription fulfillment, adhering to both federal and state pharmaceutical regulations. All patient data and communications are managed through an end-to-end encrypted, HIPAA-compliant technology platform, addressing critical privacy and security requirements.

By proactively building this robust, compliant infrastructure before its public launch, the Canadian firm has addressed many of the hurdles that can stall or derail foreign health tech companies entering the American market. This meticulous planning demonstrates a deep understanding of the U.S. healthcare system and a long-term vision for sustainable growth, providing a blueprint for Canadian innovation powered by disciplined American execution.